# Erythromycin Ethylsuccinate

NDC: 60219-1503
Generic name: Erythromycin
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20231202

FDA application: ANDA211204

## Active ingredients

- ERYTHROMYCIN ETHYLSUCCINATE: 200 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60219-1503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60219-1503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=581d7430-1a80-42a6-befb-4c3ae8140392